Cellular uptake and internalization of hyaluronan-based doxorubicin and cisplatin conjugates - Wikidata - wikimedia - TriplyDB

Cellular uptake and internalization of hyaluronan-based doxorubicin and cisplatin conjugates

Cellular uptake and internalization of hyaluronan-based doxorubicin and cisplatin conjugates

http://www.wikidata.org/entity/Q36204729

about

Valproic Acid Induces Endocytosis-Mediated Doxorubicin Internalization and Shows Synergistic Cytotoxic Effects in Hepatocellular Carcinoma Cells Hyaluronan as a therapeutic target in human diseases Hyaluronan-Lysine Cisplatin Drug Carrier for Treatment of Localized Cancers: Pharmacokinetics, Tolerability, and Efficacy in Rodents and Canines.Hyaluronic acid-nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo.Development and Validation of an Inductively Coupled Plasma Mass Spectrometry (ICP-MS) Method for Quantitative Analysis of Platinum in Plasma, Urine, and Tissues.Cell-penetrating peptide-doxorubicin conjugate loaded NGR-modified nanobubbles for ultrasound triggered drug delivery.Polymeric drug delivery systems for intraoral site-specific chemoprevention of oral cancer.Phase I-II clinical trial of hyaluronan-cisplatin nanoconjugate in dogs with naturally occurring malignant tumors.Intratracheal Administration of Hyaluronan-Cisplatin Conjugate Nanoparticles Significantly Attenuates Lung Cancer Growth in Mice.Internalized CD44s splice isoform attenuates EGFR degradation by targeting Rab7A.Tumor targeting with pH-responsive poly(2-oxazoline)-based nanogels for metronomic doxorubicin treatment.Injectable Chemotherapy Downstaged Oral Squamous Cell Carcinoma from Nonresectable to Resectable in a Rescue Dog: Diagnosis, Treatment, and Outcome

P2860

Q32177411-B57491BC-311C-4D27-AB3A-524BEBE10732 Q36578627-E8D06F9A-0907-49FB-A73D-051DD9D58950 Q36948510-347F17B1-32ED-4C1B-97FC-80F9EB7B5960 Q37733317-BFD8452B-5259-4C70-AA24-D3D0E7552733 Q38436491-675F6CEB-F1A2-4A43-950E-09CEA273B714 Q38852888-AF3079E9-26C5-42FE-9D47-CF6D0E499868 Q39398234-0529BFA4-1FCF-46A1-8D82-97A9BA1D0117 Q39436032-81336F8F-7EA8-4388-AF5C-1AEA29A0AD4E Q41656021-746F99CD-3894-4480-889C-34CBD9400D40 Q48191496-00760865-A606-4483-981C-D5BB8A329545 Q55016415-66AEE9F5-EB36-4E75-9993-6218D68AFD37 Q58580191-AC82559C-2DB4-4B2A-B86A-D560F28FDF04

P2860

Cellular uptake and internalization of hyaluronan-based doxorubicin and cisplatin conjugates

http://www.wikidata.org/entity/Q36204729

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Cellular uptake and internaliz ...... bicin and cisplatin conjugates

@ast

Cellular uptake and internaliz ...... bicin and cisplatin conjugates

@en

type

label

Cellular uptake and internaliz ...... bicin and cisplatin conjugates

@ast

Cellular uptake and internaliz ...... bicin and cisplatin conjugates

@en

prefLabel

Cellular uptake and internaliz ...... bicin and cisplatin conjugates

@ast

Cellular uptake and internaliz ...... bicin and cisplatin conjugates

@en

P1433

Q36204729-BE8273F9-825E-4781-847A-984322B1384D

P1476

Q36204729-B64E832A-465F-43C5-9741-05A38BCFA7C3

P2093

Q36204729-71B597E0-69D3-42A2-AB3E-A430143EA9C7

Q36204729-7CA9631C-CAA5-4808-8B4F-9E0FB5B155AB

Q36204729-AB2C0BAD-2884-4C71-BE30-B5DB42050A7C

Q36204729-AC153FE7-4A35-47ED-9FF3-2EADF6A7A89D

Q36204729-C218DCB4-C9F5-49AE-ABE3-43130FC82C17

Q36204729-C84D59BE-5AB2-4B53-81AB-7A92E14E6972

P2860

Q36204729-05A12190-2466-472B-989A-8CC2BA687C69

Q36204729-0A256D78-F5CB-42F2-AB9E-17EDBD364B5D

Q36204729-2BE925E2-C526-4DF2-8B8B-8CCA46C3C344

Q36204729-2C6C597D-A8B2-4414-A418-27D500D1F280

Q36204729-3081395F-D3D4-4364-82B3-4D2165DF14C0

Q36204729-3510B6A1-3E9C-4FD8-9BD9-24A02853775D

Q36204729-365AD4F7-F78D-4DA5-8214-3FBDDF6E5D66

Q36204729-3928586C-84E0-4DE0-9D56-282BF55C7595

Q36204729-4C478B97-819E-40C6-93BE-7675B9DC36FF

Q36204729-5E0DE203-0D84-4355-BD0B-014A2B8ED304

P304

Q36204729-A5634340-989D-4FCE-942E-3F2B12572EC9

P31

Q36204729-EA888166-23D6-44A1-BF01-479F3A258262

P356

Q36204729-64E8C7A4-BCE8-4233-AC71-67DB206BB3E6

P433

Q36204729-03F1B469-1D8F-4B66-AC59-103D95824A31

P478

Q36204729-4D4D0653-5869-48AE-BA17-131FFCBBE82C

P577

Q36204729-6A5128F8-8CB6-4DD9-B861-7EBF643587B0

P698

Q36204729-87B637BC-C807-4C6B-A007-D114B523AF2E

P932

Q36204729-45E64197-9C41-4877-A072-A95A2B62A762

P356

1061186X.2014.921924

P1433

Journal of Drug Targeting

P1476

Cellular uptake and internaliz ...... bicin and cisplatin conjugates

@en

P2093

Adel Ali B Alhowyan

http://www.w3.org/2001/XMLSchema#string

M Laird Forrest

http://www.w3.org/2001/XMLSchema#string

Qiuhong Yang

http://www.w3.org/2001/XMLSchema#string

Shuang Cai

http://www.w3.org/2001/XMLSchema#string

W C Melanie Forrest

http://www.w3.org/2001/XMLSchema#string

Yelizaveta Shnayder

http://www.w3.org/2001/XMLSchema#string

P2860

LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis

Carrier-based intralymphatic cisplatin chemotherapy for the treatment of metastatic squamous cell carcinoma of the head & neck.

Pulmonary delivery of cisplatin-hyaluronan conjugates via endotracheal instillation for the treatment of lung cancer.

Localized doxorubicin chemotherapy with a biopolymeric nanocarrier improves survival and reduces toxicity in xenografts of human breast cancer.

Hyaluronan: its nature, distribution, functions and turnover.

IR-780 dye loaded tumor targeting theranostic nanoparticles for NIR imaging and photothermal therapy.

Pharmacokinetics and disposition of a localized lymphatic polymeric hyaluronan conjugate of cisplatin in rodents.

Liberation of doxorubicin from HPMA copolymer conjugate is essential for the induction of cell cycle arrest and nuclear fragmentation in ovarian carcinoma cells.

Intralymphatic chemotherapy using a hyaluronan-cisplatin conjugate.

Effects of intratumoral administration of a hyaluronan-cisplatin nanoconjugate to five dogs with soft tissue sarcomas

P304

648-657

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/1061186X.2014.921924

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24892741

http://www.w3.org/2001/XMLSchema#string

P932

4620033

http://www.w3.org/2001/XMLSchema#string